Ignite Creation Date:
2025-12-24 @ 11:15 PM
Ignite Modification Date:
2025-12-25 @ 8:52 PM
Study NCT ID:
NCT03442556
Status:
TERMINATED
Last Update Posted:
2025-06-12
First Post:
2018-02-09
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency
Sponsor:
University of Washington
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-24
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-06-04
Completion Date Type:
ACTUAL
First Submit Date:
2018-02-09
First Submit QC Date:
None
Study First Post Date:
2018-02-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-09
Last Update Post Date:
2025-06-12
Last Update Post Date Type:
ACTUAL